Advancing Hepatitis B Virus Testing in Prospective Blood Donors Beyond Current Single Marker Rapid Technique: Is it a Luxury or Necessity?
Journal Title: International STD Research & Reviews - Year 2017, Vol 5, Issue 2
Abstract
Blood transfusion service comes with its various risks which include transfusion of transmissible infections especially hepatitis B. Though Nigeria is noted as a high endemic region for hepatitis B virus (HBV) infection, yet most techniques focus on detection of only hepatitis B surface antigen marker in serum or plasma. This study aims at optimizing ‘safe blood’ practice by advancing hepatitis B virus testing in prospective blood donors (PBD) beyond single marker serologic screening and estimating HBV endemicity among blood donors based on HBV markers seroprevalence. Up to 4 ml of K3EDTA anticoagulated sample was obtained from PBD and aliquot into two separate plain containers following informed consent and ethical approval. A total of four hundred and seventy (470) of PBD were initially screened for HBV markers using NOVA HBV 5-in-1 rapid one-step enzyme immunoassay between August, 2014 and November, 2015. Results were analyzed using SPSS version 21. The results showed that the overall gender ratio and mean age of PBD screened for HBV are 1.45:1 and 26.87±7.51 respectively. Chi square revealed right knowledge of most of the routes of hepatitis B viral transmission by PBD (χ2 range = 11.6 – 102.3, p < 0.05). Also, this study revealed HBsAg seroprevalence of 6.4% based on NOVA 5-in-1 rapid EIA. Cummulative HBV markers seroprevalence was 19.36% including 34 (7.23%) HBsAb+ and 1(0.21%) HBsAb+HBeAb+HBcAb+ showing evidence of vaccinated and naturally immunized donors respectively. In conclusion, the use of more stringent serologic techniques and workable algorithm to reduce risks associated with blood transfusion and enhance both blood donors’ and recipients’ safety is no longer a luxury but a necessity.
Authors and Affiliations
G. I. Amilo, M. O. Ifeanyichukwu, K. A. Fasakin
Keywords
Related Articles
- EP ID EP305425
- DOI 10.9734/ISRR/2017/32082
- Views 132
- Downloads 0
Effect of HIV Infection and Antiretroviral Therapy Duration on CD4 Count, Total and Differential White Cell Count
Aims: To assess CD4 counts, total and differential white cell counts in HIV positive patients on antiretroviral treatment (ART) and those not on antiretroviral treatments with varying durations of infection. Study Design...
90-90-90 Ambitious Targets: Achieving the Last 90 of the UNAIDS Targets in Western Nigeria
Background: In resource-limited settings, where genotypic drug resistance testing is rarely performed and poor adherence is regarded as the most common reason for treatment failure, programmatic approaches to handling tr...
Modeling the Global Public Health Determinants of HIV/AIDS-Related Deaths
The alarming global incidence of HIV/AIDS epidemic prompted this research undertaking to explore several health indicators that lead to and mediate reported HIV/AIDS mortality. A number of studies attempted to explore an...
Youths' Reproductive Health and Risk Perception to Sexually Transmitted Infections in Communities in Bayelsa State, Nigeria: A Qualitative Study
Aims: Young people especially in sub-Saharan Africa are at great risk of contracting HIV. Studies have shown that young people aged 15–24 account for an estimated 45% of new HIV infections worldwide while less than half...
Modelling Human Immunodeficiency Virus cum Tuberculosis Co-infection Dynamics in Kwande-Nigeria: An Econometrics Time Series Approach
Aims: To model the dynamics of Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) co-infection in Kwande region of Benue state in Nigeria using econometrics time series techniques. Place and Duration of Study: The...